Search company, investor...

Merus Labs - Canadian Assets

Claim your profile to get in front of buyers, investors, and analysts.

Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more.

Stage

Acquired Unit | Acquired

About Merus Labs - Canadian Assets

Merus Labs is a specialty pharmaceutical company with products for oncology, women's health, cardiovascular diseases, urology, and infectious diseases.

Headquarters Location

100 Wellington Street West Suite 2110

Toronto, Ontario, M5K 1H1,

Canada

416-593-3725

Missing: Merus Labs - Canadian Assets's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Merus Labs - Canadian Assets's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Merus Labs - Canadian Assets Frequently Asked Questions (FAQ)

Where is Merus Labs - Canadian Assets's headquarters?
Merus Labs - Canadian Assets's headquarters is located at 100 Wellington Street West, Toronto.
What is Merus Labs - Canadian Assets's latest funding round?
Merus Labs - Canadian Assets's latest funding round is Acquired Unit.
Who are the investors of Merus Labs - Canadian Assets?
Investors of Merus Labs - Canadian Assets include Searchlight Pharma.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.